Autoimmunity in Interstitial lung diseases: preliminary data from a tertiary center.

Vivarelli, Emanuele; Vitiello, Gianfranco; Tinghi, Francesco; Malandrino, Danilo; Palterer, Boaz; Torricelli, Elena; Bargagli, Elena; Rosi, Elisabetta; Parronchi, Paola

doi:10.1183/13993003.congress-2018.pa2991

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The significance of autoimmunity features/autoantibodies in ILD was also explored [42, 43]. In a retrospective study of 102 patients with high-resolution CT-defined nonspecific interstitial pneumonia (NSIP) pattern, no differences in clinical characteristics or 3-year survival were observed between patients with IPAF and idiopathic NSIP.…”

Section: Introductionmentioning

confidence: 99%

Research highlights from the 2018 ERS International Congress: interstitial lung diseases

et al. 2019

Self Cite

View full text Add to dashboard Cite

This article reviews a selection of the scientific presentations on interstitial lung disease (ILD)/diffuse parenchymal lung disease (DPLD) that were made at the 2018 European Respiratory Society (ERS) International Congress in Paris. A number of advances in the epidemiology, pathogenesis, diagnosis and treatment of these disorders were presented and discussed by clinicians and researchers. The research topics span over all four groups of ERS Assembly 12: Interstitial Lung Diseases (Group 12.01: Idiopathic interstitial pneumonias; Group 12.02: ILD/DPLD of known origin; Group 12.03: Sarcoidosis and other granulomatous ILD/DPLD; Group 12.04: Rare ILD/DPLD).

show abstract

Section: Introductionmentioning

confidence: 99%